Miami, FLNCT07023614Now EnrollingIRB Ready

Non-obstructive Hypertrophic Cardiomyopathy Clinical Trial in Miami, FL

Access cutting-edge non-obstructive hypertrophic cardiomyopathy treatment through this clinical trial at a research site in Miami. Study-provided care at no cost to qualified participants.

Sponsored by Imbria Pharmaceuticals, Inc.

Quick Self-Assessment

See if you qualify for this Miami location

Preparing your pre-screening questions…

Expert Care in Miami

Access non-obstructive hypertrophic cardiomyopathy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related non-obstructive hypertrophic cardiomyopathy treatment provided free

Apply for This Miami Location

Check if you qualify for this non-obstructive hypertrophic cardiomyopathy clinical trial in Miami, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Miami

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Miami site if eligible
  4. 4Begin participation

About This Non-obstructive Hypertrophic Cardiomyopathy Study in Miami

FORTITUDE-HCM is a global, multicenter, double-blind, parallel-group, placebo-controlled Phase 2b study that will assess the efficacy and safety of ninerafaxstat compared to placebo on top of Standard of Care in patients with symptomatic nHCM

Sponsor: Imbria Pharmaceuticals, Inc.

Who Can Participate

Inclusion Criteria

Has a clinical diagnosis of HCM consistent with current American College of Cardiology/American Heart Association and European Society of Cardiology Guideline definitions
Has had confirmation of nHCM by the echocardiography core laboratory based on screening rest and exercise stress echocardiography
New York Heart Association (NYHA) functional Class II or III at screening
Functional limitation as defined by a screening CPET Select

Exclusion Criteria

Has a known or suspected infiltrative, genetic, or storage disorder causing cardiac hypertrophy that mimics nHCM
Has any other condition judged by the investigator to be the primary cause of dyspnea, exercise intolerance, and/or angina
Has an inability to exercise on a treadmill or bicycle (eg, orthopedic limitations)
Has any medical condition that precludes upright exercise stress testing Other protocol-defined inclusion and exclusion criteria apply.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Miami?

Yes, this clinical trial (NCT07023614) has an active research site in Miami, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Non-obstructive Hypertrophic Cardiomyopathy Treatment Options in Miami, FL

If you're searching for non-obstructive hypertrophic cardiomyopathy treatment options in Miami, FL, this clinical trial (NCT07023614) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Miami research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non-obstructive hypertrophic cardiomyopathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all non-obstructive hypertrophic cardiomyopathy clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Miami, FL

See all pulmonary embolism clinical trials recruiting in Miami — not just this study.

Browse Pulmonary Embolism Trials in Miami

Ready to Join in Miami?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Miami, FL